ArticleCancer medicine2020

Clinical outcomes of newly diagnosed primary CNS lymphoma treated with ibrutinib-based combination therapy: A real-world experience of off-label ibrutinib use.

Feili Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.